| Specimen Type | Specimen Requirement | Special Instructions |
|---|---|---|
| Abscess contents, aspirated fluid | As much as possible in sterile disposable container. | Disinfect skin with 70% alcohol before aspiration. Use swab to collect only if the volume is insufficient for aspiration. Aspirate material from under the margin of the lesion/abscess. Laboratory may provide 7H9 broth for transport of small volumes of aspirates. |
| Blood | 5ml of plain blood inoculated directly into Myco-F-Lytic vial.** On rare occasions, if blood culture vials are not available, blood and bone marrow may be submitted in Vacutainer tubes containing SPS, heparin or citrate. EDTA tubes are not acceptable | Disinfect skin with 70% alcohol. Disinfect cap of Myco-F-Lytic vial with alcohol. Mix the contents immediately after collection. Mainly performed for immunocompromised patients, particularly those with AIDS. Please indicate such underlying condition on the form as prolonged culture incubation may be required. Do not refrigerate or freeze blood specimens |
| Body fluids (pleural, pericardial, peritoneal, etc) | As much as possible (minimum 10 - 15ml) in a sterile leak-proof, screw-capped, single-use container. |
Disinfect skin with 70% alcohol if collecting by needle and syringe. |
| Bone | Bone in sterile disposable container with no fixative or preservative. |
Do not submit specimen in formalin. |
| Bone marrow | Inoculate directly into Myco-F-Lytic vial.** If direct molecular testing is required, then collect at least 3 ml in a sterile, screw-capped disposable container. |
As for blood |
| Bronchoalveolar lavage or bronchial washing/brushing |
≥ 5 ml in sterile disposable container | Avoid contaminating bronchoscope with tap water as free-living saprophytic mycobacteria may produce false-positive results. |
| CSF | ≥2 ml in sterile disposable container | Disinfect skin before aspiration. Do not refrigerate or freeze. |
| Gastric lavage | ≥5 - 10 ml in sterile disposable container. Collect in the morning soon after patient awakens in order to obtain sputum swallowed during sleep. | Collect a fasting early morning sample on 3 consecutive days. Unless contraindicated, use 25 to 50ml of chilled, sterile saline. Collect in container containing 100 mg of sodium carbonate per 50 ml of total fluid if delivery is expected to be delayed for > 4 hours.** |
| Laryngeal swabs | Unless the patient is suspected to have laryngeal TB, laryngeal swabs are not recommended for diagnosing pulmonary TB due to the following reasons: |
|
| Lymph node | Node or portion of node in sterile disposable container with no fixative or preservative. Minute amounts may be submitted in a 1-2 ml of sterile saline. |
Collect aseptically. Select caseous portion if available. Do not freeze, immerse in formalin or other preservatives or wrap in gauze. |
| Skin lesion material | Send biopsy specimen or aspirate in sterile disposable container with no fixative or preservative. | For cutaneous ulcers, collect biopsy sample from periphery of lesion or aspirate material from under margin of lesion. Swabs in transport medium are acceptable only if biopsy sample or aspirate is not obtainable. If infection was acquired in Africa, Australia, Mexico, South America, Indonesia, New Guinea or Malaysia, state this on request form, because Mycobacterium ulcerans requires prolonged incubation for primary isolation. |
| Sputum | 5 - 10ml in sterile, wax-free disposable specimen container. | Instruct patient to rinse mouth before sputum is collected. Collect 2-3 consecutive deep productive cough sputum samples in an 8 to 24 hour period; one of which should be a first morning specimen before any oral intake. Do not pool specimens (e.g. 24-hr pooled sputum); such samples and saliva are unacceptable. Induced sputum can be collected from patients who cannot or find it difficult to expectorate. For induced sputum, use sterile hypertonic saline. Avoid sputum contamination with nebuliser reservoir water. Indicate induced sputum on request form as these watery specimens resemble saliva. |
| Stool | ≥1g in sterile, disposable wax-free container | Collect the specimen directly into the container or transfer from the bedpan. Recommended only for the detection of Mycobacterium avium complex (MAC) involvement in the gastrointestinal tracts of patients with AIDS. Refrigerate if delay in transportation is expected, but do not freeze. |
| Tissue biopsy sample | 1g of tissue, if possible, in sterile disposable container with no fixative or preservative. Minute amounts may be submitted in a 1-2 ml of sterile saline. |
Collect aseptically. Select caseous portion if available. Do not freeze, immerse in formalin or other preservatives or wrap in gauze |
| Transtracheal aspirate | As much as possible in a sterile, leak-proof disposable container |
|
| Urine | Clean the urethral area with distilled or cooled boiled water (tap water may contain saprophytic bacteria). Mid-stream urine is not advisable. Collect at least 40ml in a sterile, leak-proof disposable container. For suprapubic urine, collect as much as possible in a sterile disposable container. |
Collect first morning specimen on three consecutive days. The first morning void provides the best yield. Specimens collected at other times are diluted and not optimal. Specimens of < 40ml are unacceptable unless a larger volume is not obtainable. An early morning midstream urine is acceptable only if an early morning urine sample is not available. 24-hour pooled specimens or urine from a catheter bag are unacceptable. A small fraction of patients undergoing BCG immunotherapy for bladder cancer may have local or even disseminated disease from BCG. For 95% of such patients, serious side effects do not occur and BCG isolation from urine does not have clinical significance. Routine urine culture for mycobacteria in this setting is not recommended. |
| Wound material | See biopsy or aspirate | Due to limited material collected, swabs are acceptable only if biopsy or aspirate is not obtainable; negative results may not be reliable. If used, use a sterile swab moistened with sterile saline; do not use eSwab. |
| Specimens for nucleic acid amplification (BD Max MDR-TB or Xpert MTB/RIF Ultra Assay) |
All specimens, as for culture. Specimens in transport swabs are not acceptable. |
To avoid false positives from cross contamination, specimens should not be pre-processed in other labs. If delay in delivery is expected, store at 4ºC. |
| Blood for Quantiferon testing | The Quantiferon-Plus tubes may be obtained from Client & Specimen Management (CSM) as follows:
|
Use a butterfly needle or vacutainer system - using hypodermic syringes increases the risk of sharps injury. Purge the contents of the butterfly tubing with a plain tube first. 4. If the level of blood in any tube is not close to or exceeds the indicator line, another blood sample should be obtained.
Mixing Post collection, mix the blood with the tube contents by shaking tubes 10 times, to ensure that the entire inner surface of the tubes are coated with blood. Foaming may be expected and this will not affect the result. The shaking should not be so hard as to disrupt the gel at the base of the tubes as this may cause aberrant results.
Transportation Transport the tubes at room temperature (22 +/- 5ºC) to CSM before 1630 hrs on the same day of blood collection. It is not necessary for them to be transported upright. Timing Specimens must be received at CTBL within 16 hours of sample collection on Mon-Fri between 8.30 am - 5.00 pm. They will not be accepted on Saturday, Sunday, eve of public holidays and on public holidays. |
Available upon request from CSM**
Click here to view all Mycobacteriology tests